277 related articles for article (PubMed ID: 34503458)
1. Fewer losses in the cascade of care for latent tuberculosis with solo interferon-gamma release assay screening compared to sequential screening.
Lim RK; Talavlikar R; Chiazor O; Bietz J; Gardiner H; Fisher D
BMC Infect Dis; 2021 Sep; 21(1):936. PubMed ID: 34503458
[TBL] [Abstract][Full Text] [Related]
2. Comparing the cost-effectiveness of two screening strategies for latent tuberculosis infection in Portugal.
Sousa S; Rocha D; Silva JC; Ribeiro AI; Gonçalves G; Almeida Á; Correia AM; Duarte R; Carvalho C
Pulmonology; 2021; 27(6):493-499. PubMed ID: 34053903
[TBL] [Abstract][Full Text] [Related]
3. A systematic review on TST and IGRA tests used for diagnosis of LTBI in immigrants.
Campbell JR; Krot J; Elwood K; Cook V; Marra F
Mol Diagn Ther; 2015 Feb; 19(1):9-24. PubMed ID: 25579159
[TBL] [Abstract][Full Text] [Related]
4. Interferon-γ release assay as a sensitive diagnostic tool of latent tuberculosis infection in patients with HIV: a cross-sectional study.
Klautau GB; da Mota NVF; Salles MJC; Burattini MN; Rodrigues DS
BMC Infect Dis; 2018 Nov; 18(1):585. PubMed ID: 30453903
[TBL] [Abstract][Full Text] [Related]
5. A Step toward Tuberculosis Elimination in a Low-Incidence Country: Successful Diagnosis and Treatment of Latent Tuberculosis Infection in a Refugee Clinic.
Rennert-May E; Hansen E; Zadeh T; Krinke V; Houston S; Cooper R
Can Respir J; 2016; 2016():7980869. PubMed ID: 27445565
[TBL] [Abstract][Full Text] [Related]
6. Two interferon gamma release assays for predicting active tuberculosis: the UK PREDICT TB prognostic test study.
Abubakar I; Lalvani A; Southern J; Sitch A; Jackson C; Onyimadu O; Lipman M; Deeks JJ; Griffiths C; Bothamley G; Kon OM; Hayward A; Lord J; Drobniewski F
Health Technol Assess; 2018 Oct; 22(56):1-96. PubMed ID: 30334521
[TBL] [Abstract][Full Text] [Related]
7. Tuberculosis screening among HIV-infected patients: tuberculin skin test vs. interferon-gamma release assay.
Adams JW; Howe CJ; Andrews AC; Allen SL; Vinnard C
AIDS Care; 2017 Dec; 29(12):1504-1509. PubMed ID: 28486818
[TBL] [Abstract][Full Text] [Related]
8. US Postarrival Evaluation of Immigrant and Refugee Children with Latent Tuberculosis Infection Diagnosed Overseas, 2007-2019.
Wang Z; Posey DL; Brostrom RJ; Morris SB; Marano N; Phares CR
J Pediatr; 2022 Jun; 245():149-157.e1. PubMed ID: 35120982
[TBL] [Abstract][Full Text] [Related]
9. Tuberculosis infection in under-2-year-old refugees: Should we be screening? A systematic review and meta-regression analysis.
Ghosh S; Dronavalli M; Raman S
J Paediatr Child Health; 2020 Apr; 56(4):622-629. PubMed ID: 31883282
[TBL] [Abstract][Full Text] [Related]
10. Latent tuberculosis may be missed by current screening practices: Analysis of interferon-gamma release assay results from a paediatric refugee clinic.
Colgan K; Anderson J; Maycock A; Britton PN; Mackenzie M; Isaacs D; Gunasekera H
J Paediatr Child Health; 2019 Jul; 55(7):826-832. PubMed ID: 30565764
[TBL] [Abstract][Full Text] [Related]
11. Lessons Learned from Implementation of an Interferon Gamma Release Assay to Screen for Latent Tuberculosis Infection in a Large Multicenter Observational Cohort Study in Brazil.
Costa AG; Carvalho BKS; Araújo-Pereira M; Ibiapina HNS; Spener-Gomes R; Souza AB; Gomes-Silva A; Andrade AMS; Silva EC; Arriaga MB; Benjamin A; Rocha MS; Moreira ASR; Oliveira JG; Figueiredo MC; Turner MM; Durovni B; Cavalcante S; Kritski AL; Rolla VC; Sterling TR; Andrade BB; Cordeiro-Santos M;
Microbiol Spectr; 2021 Dec; 9(3):e0116321. PubMed ID: 34851140
[TBL] [Abstract][Full Text] [Related]
12. Interferon-γ Release Assays for Tuberculosis Infection Diagnosis in Refugees <5 Years Old.
Wendorf KA; Lowenthal P; Feraud J; Cabanting N; Murto C
Pediatrics; 2020 Oct; 146(4):. PubMed ID: 32994177
[TBL] [Abstract][Full Text] [Related]
13. Community treatment of latent tuberculosis in child and adult refugee populations: outcomes and successes.
Harwood-Johnson E; Leis KS; Hanson J; Olfert J; Blonde Y; Brindamour M
Front Public Health; 2023; 11():1225217. PubMed ID: 37942244
[TBL] [Abstract][Full Text] [Related]
14. The use of an interferon-gamma release assay to screen for pediatric latent tuberculosis infection in the eastern region of the Emirate of Abu Dhabi.
Al Mekaini LA; Al Jabri ON; Narchi H; Kamal SM; Mabrook A; Al Kuwaiti MM; Sheek-Hussein MM; Souid AK; Alsuwaidi AR
Int J Infect Dis; 2014 Jun; 23():4-7. PubMed ID: 24657274
[TBL] [Abstract][Full Text] [Related]
15. Comparison of latent tuberculosis infection screening strategies before tumor necrosis factor inhibitor treatment in inflammatory arthritis: IGRA-alone versus combination of TST and IGRA.
Jeong DH; Kang J; Jung YJ; Yoo B; Lee CK; Kim YG; Hong S; Shim TS; Jo KW
PLoS One; 2018; 13(7):e0198756. PubMed ID: 29975703
[TBL] [Abstract][Full Text] [Related]
16. Screening for latent tuberculosis infection: performance of tuberculin skin test and interferon-γ release assays under real-life conditions.
Kleinert S; Tony HP; Krueger K; Detert J; Mielke F; Rockwitz K; Schwenke R; Burmester GR; Diel R; Feuchtenberger M; Kneitz C
Ann Rheum Dis; 2012 Nov; 71(11):1791-5. PubMed ID: 22586160
[TBL] [Abstract][Full Text] [Related]
17. Screening of latent tuberculosis infection among health care workers working in Hajj pilgrimage area in Saudi Arabia, using interferon gamma release assay and tuberculin skin test.
Bukhary ZA; Amer SM; Emara MM; Abdalla ME; Ali SA
Ann Saudi Med; 2018; 38(2):90-96. PubMed ID: 29620541
[TBL] [Abstract][Full Text] [Related]
18. Contribution of a heparin-binding haemagglutinin interferon-gamma release assay to the detection of Mycobacterium tuberculosis infection in HIV-infected patients: comparison with the tuberculin skin test and the QuantiFERON-TB Gold In-tube.
Wyndham-Thomas C; Dirix V; Schepers K; Martin C; Hildebrand M; Goffard JC; Domont F; Libin M; Loyens M; Locht C; Van Vooren JP; Mascart F
BMC Infect Dis; 2015 Feb; 15():59. PubMed ID: 25886172
[TBL] [Abstract][Full Text] [Related]
19. Latent Tuberculosis Infection Cascade of Care among Asylum Seekers in Verona, Italy.
Bordin P; Gazzani D; Postiglione C; Conti E; Colucci L; Napoletano G; Bosco O; Moretti F; Majori S
J Health Care Poor Underserved; 2022; 33(2):934-949. PubMed ID: 35574886
[TBL] [Abstract][Full Text] [Related]
20. Interferon gamma release assay tests are associated with persistence and completion of latent tuberculosis infection treatment in the United States: Evidence from commercial insurance data.
Stockbridge EL; Loethen AD; Annan E; Miller TL
PLoS One; 2020; 15(12):e0243102. PubMed ID: 33270737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
